PAPER Sung MS, Choi SM, Kim J, Ha JY, Kim BC, Heo H, Park SW

Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson's disease.

Sci Rep. 2019 Aug 14;9(1):11832. PubMed: 31413302

PAPER Miah J, Dawes P, Edwards S, Leroi I, Starling B, Parsons S

Patient and public involvement in dementia research in the European Union: a scoping review.

BMC Geriatr. 2019 Aug 14;19(1):220. PubMed: 31412788

PAPER Sügis E, Dauvillier J, Leontjeva A, Adler P, Hindie V, Moncion T, Collura V, Daudin R, Loe-Mie Y, Herault Y, Lambert JC, Hermjakob H, Pupko T, Rain JC, Xenarios I, Vilo J, Simonneau M, Peterson H

HENA, heterogeneous network-based data set for Alzheimer's disease.

Sci Data. 2019 Aug 14;6(1):151. PubMed: 31413325

PAPER Read J, Suphioglu C

Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.

Cell Physiol Biochem. 2019;53(2):413-428. PubMed: 31415717

PAPER Shang J, Yamashita T, Tian F, Li X, Liu X, Shi X, Nakano Y, Tsunoda K, Nomura E, Sasaki R, Tadokoro K, Sato K, Takemoto M, Hishikawa N, Ohta Y, Abe K

Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.

Brain Res. 2019 Nov 15;1723:146379. Epub 2019 Aug 12 PubMed: 31415766

PAPER Mancuso R, Sicurella M, Agostini S, Marconi P, Clerici M

Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):715-731. Epub 2019 Aug 23 PubMed: 31414935

PAPER McAlary L, Plotkin SS, Cashman NR

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.

CNS Drugs. 2019 Sep;33(9):883-904. PubMed: 31414322

PAPER Tian J, Guo L, Sui S, Driskill C, Phensy A, Wang Q, Gauba E, Zigman JM, Swerdlow RH, Kroener S, Du H

Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Sci Transl Med. 2019 Aug 14;11(505) PubMed: 31413143

PAPER Kakati T, Bhattacharyya DK, Barah P, Kalita JK

Comparison of Methods for Differential Co-expression Analysis for Disease Biomarker Prediction.

Comput Biol Med. 2019 Oct;113:103380. Epub 2019 Aug 10 PubMed: 31415946

PAPER Yamazaki T, Inui Y, Ichihara T, Uno M, Ota S, Toyoda A, Ishiguro M, Kato T, Ito K, Toyama H

Clinical utility of the normal database of 123I-iodoamphetamine brain perfusion single photon emission computed tomography for statistical analysis using computed tomography-based attenuation correction: a multicenter study.

Ann Nucl Med. 2019 Nov;33(11):835-841. Epub 2019 Aug 14 PubMed: 31414335

PAPER Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CA, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR

Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.

Acta Neuropathol. 2019 Dec;138(6):913-941. Epub 2019 Aug 14 PubMed: 31414210

PAPER Xu Y, Zhang Z, Jiang X, Chen X, Wang Z, Alsulami H, Qin HL, Tang W

Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.

Eur J Med Chem. 2019 Nov 1;181:111598. Epub 2019 Aug 6 PubMed: 31415981

PAPER Riquelme A, Valdés-Tovar M, Ugalde O, Maya-Ampudia V, Fernández M, Mendoza-Durán L, Rodríguez-Cárdenas L, Benítez-King G

Potential Use of Exfoliated and Cultured Olfactory Neuronal Precursors for In Vivo Alzheimer's Disease Diagnosis: A Pilot Study.

Cell Mol Neurobiol. 2020 Jan;40(1):87-98. Epub 2019 Aug 14 PubMed: 31414299

PAPER Marín-Lahoz J, Sampedro F, Martinez-Horta S, Pagonabarraga J, Kulisevsky J

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease.

Ann Neurol. 2019 Nov;86(5):762-769. Epub 2019 Aug 31 PubMed: 31415102

PAPER Lim B, Tsolaki M, Soosaipillai A, Brown M, Zilakaki M, Tagaraki F, Fotiou D, Koutsouraki E, Grosi E, Prassas I, Diamandis EP

Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.

Clin Chem Lab Med. 2019 Nov 26;57(12):1875-1881. PubMed: 31415236